Eloxx Pharmaceuticals Inc (ELOX)

$0.13 +0.01 (8.33%)
Market Cap 408,000.00
Revenue (ttm) 0.00
Net Income (ttm) -6.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.08
Volume 26,000
Avg Vol 11,082
Day's Range N/A - N/A
Shares Out 3.14M
Stochastic %K 34%
Beta -1,963.32
Analysts Strong Buy
Price Target $30.00

Company Profile

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, an...

Industry: Biotechnology
Sector: Healthcare
Phone: 781 577 5300
Address:
10 Court Street, P.O. Box 274, Arlington, United States
cotsl
cotsl Mar. 25 at 4:57 PM
$ELOX on page F-38 of the recent 10-K: "As of February 26, 2026, the Company had no remaining outstanding debt obligations. On March 12, 2026, the Company received $2.0 million from Domicilium, in return for a pre-funded warrant to purchase up to 4,081,632 shares of its common stock as an exercise price of $0.01 per share, based on a purchase price of $0.49 per share of underlying common stock."
0 · Reply
cotsl
cotsl Mar. 25 at 4:56 PM
$ELOX on page F-37 of the recent 10-K: "on February 26, 2026, the Coastlands Third Tranche Closing occurred and the Company received $5.0 million in return for a pre-funded warrant to purchase up to 10,204,081 shares of its common stock at an exercise price of $0.01 per share, based on a purchase price of $0.49 per share of underlying common stock."
0 · Reply
cotsl
cotsl Mar. 25 at 4:16 PM
$ELOX Out of the Expert Mkt last week; was 3.82 before the 10/16/2023 delist from Nasdaq; updated website ©2026 (including great Officers and Directors); patented technology to treat cancer and inflammatory diseases.
0 · Reply
Sonibomman
Sonibomman Mar. 17 at 3:00 AM
$INDO $AGIG $REI $ELOX A fresh drone and rocket attack struck the US embassy in Baghdad early Tuesday
0 · Reply
Parobull
Parobull Oct. 17 at 7:38 AM
Watch VRME What’s rare a microcap that has both a real cash cushion and a shot at technical reentry. $VRME’s 2.5% short interest 308,895 shares) means borrow pressure is light.  As it bottom builds and technicals align, the narrative could shift fast. $CLWT $DUOT $ELOX $PRST
0 · Reply
KobeSetups
KobeSetups Sep. 24 at 11:14 AM
XPON is sitting on a lithium-focused business model with multi-sector reach. The chart looks bottomed, the float is light, and any momentum from energy or Trump-sector headlines could trigger a move. It has the setup and the range to move 2x–3x fast. $ELOX $IGC $RCAT $NGM
1 · Reply
Rebel444
Rebel444 Jun. 11 at 6:12 PM
$ELOX what going on with this ?? Anyone ??
1 · Reply
JMJTrading
JMJTrading May. 2 at 2:50 PM
$BLMZ Unbelievable setup here, the fueling is unreal, 30's soon! $ELOX $AGRX
0 · Reply
JMJTrading
JMJTrading Apr. 25 at 7:43 PM
$BLMZ Bullish, slapping all the way to 30 cents! $JBDI $ELOX $LCFY
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 9:57 PM
$ELOX Risky biotech play. ELX-02 shows promise in Alport syndrome. Watching closely for FDA trial updates. Small position. impressive article: https://beyondspx.com/article/eloxx-pharmaceuticals-elox-pioneering-ribosomal-rna-targeted-therapies-for-rare-diseases
0 · Reply
Latest News on ELOX
No data available.
cotsl
cotsl Mar. 25 at 4:57 PM
$ELOX on page F-38 of the recent 10-K: "As of February 26, 2026, the Company had no remaining outstanding debt obligations. On March 12, 2026, the Company received $2.0 million from Domicilium, in return for a pre-funded warrant to purchase up to 4,081,632 shares of its common stock as an exercise price of $0.01 per share, based on a purchase price of $0.49 per share of underlying common stock."
0 · Reply
cotsl
cotsl Mar. 25 at 4:56 PM
$ELOX on page F-37 of the recent 10-K: "on February 26, 2026, the Coastlands Third Tranche Closing occurred and the Company received $5.0 million in return for a pre-funded warrant to purchase up to 10,204,081 shares of its common stock at an exercise price of $0.01 per share, based on a purchase price of $0.49 per share of underlying common stock."
0 · Reply
cotsl
cotsl Mar. 25 at 4:16 PM
$ELOX Out of the Expert Mkt last week; was 3.82 before the 10/16/2023 delist from Nasdaq; updated website ©2026 (including great Officers and Directors); patented technology to treat cancer and inflammatory diseases.
0 · Reply
Sonibomman
Sonibomman Mar. 17 at 3:00 AM
$INDO $AGIG $REI $ELOX A fresh drone and rocket attack struck the US embassy in Baghdad early Tuesday
0 · Reply
Parobull
Parobull Oct. 17 at 7:38 AM
Watch VRME What’s rare a microcap that has both a real cash cushion and a shot at technical reentry. $VRME’s 2.5% short interest 308,895 shares) means borrow pressure is light.  As it bottom builds and technicals align, the narrative could shift fast. $CLWT $DUOT $ELOX $PRST
0 · Reply
KobeSetups
KobeSetups Sep. 24 at 11:14 AM
XPON is sitting on a lithium-focused business model with multi-sector reach. The chart looks bottomed, the float is light, and any momentum from energy or Trump-sector headlines could trigger a move. It has the setup and the range to move 2x–3x fast. $ELOX $IGC $RCAT $NGM
1 · Reply
Rebel444
Rebel444 Jun. 11 at 6:12 PM
$ELOX what going on with this ?? Anyone ??
1 · Reply
JMJTrading
JMJTrading May. 2 at 2:50 PM
$BLMZ Unbelievable setup here, the fueling is unreal, 30's soon! $ELOX $AGRX
0 · Reply
JMJTrading
JMJTrading Apr. 25 at 7:43 PM
$BLMZ Bullish, slapping all the way to 30 cents! $JBDI $ELOX $LCFY
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 21 at 9:57 PM
$ELOX Risky biotech play. ELX-02 shows promise in Alport syndrome. Watching closely for FDA trial updates. Small position. impressive article: https://beyondspx.com/article/eloxx-pharmaceuticals-elox-pioneering-ribosomal-rna-targeted-therapies-for-rare-diseases
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 28 at 3:43 AM
$ELOX Eloxx Pharmaceuticals, Inc. (OTC: ELOX): Navigating the Challenges of Rare Disease Drug Development https://beyondspx.com/article/eloxx-pharmaceuticals-elox-a-pioneer-in-ribosomal-rna-targeted-therapies-for-rare-diseases
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 3 at 7:47 PM
$ELOX Eloxx Pharmaceuticals (ELOX): A Pioneer in Ribosomal RNA-Targeted Therapies for Rare Diseases https://beyondspx.com/article/eloxx-pharmaceuticals-elox-a-pioneer-in-ribosomal-rna-targeted-therapies-for-rare-diseases
0 · Reply
JMJTrading
JMJTrading Nov. 18 at 7:43 PM
$ELOX $TUYA $COSM $VRAX
0 · Reply
JMJTrading
JMJTrading Nov. 18 at 7:03 PM
$TUYA Should be a steady riser until earning here in a few hours $$$$ This has been a sleeping monster, much to be revealed at the earning call $$$ $VRAX $COSM $ELOX
2 · Reply
Ramnar
Ramnar Oct. 19 at 11:09 AM
$ELOX down by 98% since this video is posted.. just an fyi @Toptradersam
0 · Reply
PenkeInvesting
PenkeInvesting Sep. 10 at 4:21 AM
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Eloxx Pharmaceuticals Inc. Is that bullish or bearish? $ELOX #ELOX #pink #tradingsignals #technicalanalysis
0 · Reply
Joe_Trader_CPA
Joe_Trader_CPA Aug. 15 at 3:21 PM
$ELOX does anybody know what is happening with this stock?
1 · Reply
nlstbro
nlstbro Aug. 14 at 8:29 PM
$ELOX Fucking CEO is saying they have NO MONEY to Hire Accountant. where did the $3M Go?
2 · Reply
NVDAMillionaire
NVDAMillionaire Aug. 2 at 7:11 AM
$ELOX Eloxx Pharmaceuticals, Inc. (OTC: ELOX): Navigating the Challenges of Rare Disease Drug Development http://beyondspx.com/2024/08/01/eloxx-pharmaceuticals-inc-otc-elox-navigating-the-challenges-of-rare-disease-drug-development/
0 · Reply
Odyssay
Odyssay Jul. 10 at 1:03 PM
$ELOX $OTIC $SCPXD $VGFCQ $ZVOI Jeff Wolf is the kind of guy who doesn't care for others, especially shareholders who kept his company alive. The way he is paying them back is Demonic! He is an Evil!
2 · Reply
Smallsmall
Smallsmall Jul. 10 at 9:47 AM
Serious question. What should I do with my OTC and delisted? The delisted stocks never seem to go away so I can not take the loss on them because I can’t sell them. The OTC’s are worth so little. Hold forever hoping for a buyout? Sell and move on? Thanks in advance! $SCPXD $ELOX $OTIC $ZVOI $VGFCQ
2 · Reply